[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Correction
January 7, 2009

Unreported Financial Disclosures in: Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer

JAMA. 2009;301(1):38. doi:10.1001/jama.301.1.38

Unreported Financial Disclosures: In the Original Contribution titled “Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer,” published in the July 9, 2008, issue of JAMA (2008;300[2]:173-181), the authors failed to report financial disclosures on page 180. The financial disclosures should have read, “Dr Siu-Long Yao reported that during the last 5 years he has been employed by Sanofi-Aventis and Schering-Plough in the area of clinical cancer research. Dr Grace Lu-Yao reported having received clinical research funding from the New Jersey Commission on Cancer Research and the Agency for Healthcare Research and Quality and employment with HealthStat. Dr Albertson reported having received clinical research funding from Sanofi-Aventis and consultation fees from Blue Cross/Blue Shield. Dr Shih reported having received clinical research funding from Myriad.”

×